Open AccessThe Prognostic Impact of Hormonal Receptor and HER-2 Expression Discordance in Metastatic Breast Cancer Patients
Author(s) -
Ziyan Yang,
Nani Li,
Xin Li,
Lei Lei,
Xiaojia Wang
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s231493
Subject(s) - breast cancer , medicine , metastatic breast cancer , hormone , oncology , receptor , hormone receptor , cancer research , cancer , bioinformatics , biology
Hormone receptor (HR) and human epidermal growth factor receptor (HER2) discordance between primary and metastatic breast cancer lesions is common. However, its impact on long-term survival remains unclear. We aimed to determine the prognostic value of this discordance in patients with metastaticf breast cancer (MBC).